Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders

Margolskee, Elizabeth; Jobanputra, Vaidehi; Jain, Preti; Chen, Jinli; Ganapathi, Karthik; Nahum, Odelia; Levy, Brynn; Morscio, Julie; Vundavalli, Murty V.; Tousseyn, Thomas; Alobeid, Bachir; Mansukhani, Mahesh M.; Bhagat, Govind

Post-transplant lymphoproliferative disorders of T- or NK-cell origin (T/NK-PTLD) are rare entities and their genetic basis is unclear. We performed targeted sequencing of 465 cancer-related genes and high-resolution copy number analysis in 17 T-PTLD and 2 NK-PTLD cases. Overall, 377 variants were detected, with an average of 20 variants per case. Mutations of epigenetic modifier genes (TET2, KMT2C, KMT2D, DNMT3A, ARID1B, ARID2, KDM6B, n=11). and inactivation of TP53 by mutation and/ or deletion (n=6) were the most frequent alterations, seen across disease subtypes, followed by mutations of JAK/STAT pathway genes (n=5). Novel variants, including mutations in TBX3 (n=3), MED12 (n=3) and MTOR (n=1), were observed as well. High-level microsatellite instability was seen in 1 of 14 (7%) cases, which had a heterozygous PMS2 mutation. Complex copy number changes were detected in 8 of 16 (50%) cases and disease subtype-specific aberrations were also identified. In contrast to B-cell PTLDs, the molecular and genomic alterations observed in T/ NK-PTLD appear similar to those reported for peripheral T-cell lymphomas occurring in immunocompetent hosts, which may suggest common genetic mechanisms of lymphoma development.


Downloadable resources are currently unavailable for this item.

Also Published In

More About This Work

Academic Units
Pathology and Cell Biology
Published Here
August 30, 2019